---
title: "Enhertu (fam-trastuzumab deruxtecan-nxki), all indications: Access and coverage questions"
description: "Access and coverage questions on Enhertu (fam-trastuzumab deruxtecan-nxki) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Access and support. Questions: Is there an Enhertu savings program for patients? Is there an Enhertu patient assistance program? 2 questions quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/enhertu/access-and-coverage"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Enhertu (fam-trastuzumab deruxtecan-nxki), all indications: Access and coverage questions

Manufacturer: Daiichi Sankyo, Inc.; AstraZeneca Pharmaceuticals LP  
Prescribing information: [Enhertu](https://daiichisankyo.us/prescribing-information-portlet/getPIContent?productName=Enhertu&inline=true)  
Indication pages: [HR-positive HER2-low or HER2-ultralow breast cancer](https://www.evicenter.com/medical-information/enhertu--hr-positive-her2-low-or-her2-ultralow-breast-cancer)

## Access and support

<a id="enhertu-savings-program"></a>

### Is there an Enhertu savings program for patients?

> “ENHERTU4U provides support resources for patients prescribed ENHERTU”

Source: [ENHERTU: Support and Resources for Healthcare Professionals, captured 2026-11-13](https://www.enhertuhcp.com/en/support-and-resources/for-healthcare-professionals#:~:text=ENHERTU4U%20provides%20support%20resources%20for%20patients%20prescribed%20ENHERTU)

> “$0 ENHERTU Patient Savings Program”

Source: [ENHERTU: Support and Resources for Healthcare Professionals, captured 2026-11-13](https://www.enhertuhcp.com/en/support-and-resources/for-healthcare-professionals#:~:text=%240%20ENHERTU%20Patient%20Savings%20Program)

> “To receive support for your patients and obtain more information about reimbursement, visit ENHERTU4U.com or call 1-833-ENHERTU (1-833-364-3788)”

Source: [ENHERTU: Support and Resources for Healthcare Professionals, captured 2026-11-13](https://www.enhertuhcp.com/en/support-and-resources/for-healthcare-professionals#:~:text=To%20receive%20support%20for%20your,ENHERTU4U.com%20or%20call%201%2D833%2DENHERTU%20%281%2D833%2D364%2D3788%29)

Note: The captured Enhertu HCP support page (November 13, 2026) names the program without its eligibility terms, such as insurance type, exclusions for patients with government insurance, or annual maximums, and refers to ENHERTU4U.com, which was not captured. The program name states $0; the page does not say who qualifies or which costs it covers.

<a id="enhertu-patient-assistance"></a>

### Is there an Enhertu patient assistance program?

> “ENHERTU4U provides support resources for patients prescribed ENHERTU”

Source: [ENHERTU: Support and Resources for Healthcare Professionals, captured 2026-11-13](https://www.enhertuhcp.com/en/support-and-resources/for-healthcare-professionals#:~:text=ENHERTU4U%20provides%20support%20resources%20for%20patients%20prescribed%20ENHERTU)

> “Patient Assistance Program”

Source: [ENHERTU: Support and Resources for Healthcare Professionals, captured 2026-11-13](https://www.enhertuhcp.com/en/support-and-resources/for-healthcare-professionals#:~:text=Patient%20Assistance%20Program)

> “To receive support for your patients and obtain more information about reimbursement, visit ENHERTU4U.com or call 1-833-ENHERTU (1-833-364-3788)”

Source: [ENHERTU: Support and Resources for Healthcare Professionals, captured 2026-11-13](https://www.enhertuhcp.com/en/support-and-resources/for-healthcare-professionals#:~:text=To%20receive%20support%20for%20your,ENHERTU4U.com%20or%20call%201%2D833%2DENHERTU%20%281%2D833%2D364%2D3788%29)

Note: The captured Enhertu HCP support page (November 13, 2026) names the Patient Assistance Program without eligibility terms, such as insurance status or income limits, and refers to ENHERTU4U.com, which was not captured.

## Related pages
- [Medical information: Enhertu (fam-trastuzumab deruxtecan-nxki): All indications](https://www.evicenter.com/medical-information/enhertu)
- [Indication](https://www.evicenter.com/medical-information/enhertu/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/enhertu/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/enhertu/safety)
- [Specific populations](https://www.evicenter.com/medical-information/enhertu/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/enhertu/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/enhertu/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/enhertu/storage-and-supply)
- [Guidelines](https://www.evicenter.com/medical-information/enhertu/guidelines)
